Private Equity Investment into IVF

Examining private equity’s role in fertility care

2:30 PM

View Transcript

In a recent paper published in JAMA, researchers find that over 50% of IVF cycles in the United States are now done at fertility clinics affiliated with private equity firms. Read the full article here.

Transcript

Host: 

Welcome to Health Lab, your destination for news and stories about the future of healthcare. 

Today: We’re looking at when private equity invests in IVF, and examining private equity’s role in fertility care.

Researchers find over 50% of IVF cycles are now done at fertility clinics affiliated with private equity firms.

Over the past decade, the rise of private equity firms investing in health care facilities across the United States has been exploding, and because of that rapid growth, researchers have begun digging into what this could mean for health care and patients in the long term. 

In recent years, private equity firms have become much more active in the fertility space, where many patients seek care for reproductive issues and pursue in vitro fertilization, or IVF, which costs thousands of dollars, and usually isn’t covered by insurance.

James Dupree, M.D., M.P.H., and his colleagues wanted to explore what these changes could mean for patients with infertility. 

Dr. Dupree is a professor of urology and obstetrics and gynecology at the University of Michigan Medical School, who directs U-M Health’s Male Fertility Preservation Program and studies fertility care.

In their recent paper, published in JAMA, the team shows that since 2013, expansive growth has been seen in affiliations between fertility clinics and private equity firms. 

They also find that over half of the IVF cycles in the country in 2023 were done at clinics affiliated with private equity firms. 

Further examination of the links between IVF clinics and private equity show that a federal law requires every fertility clinic to report data about their IVF cycles to the federal Centers for Disease Control and Prevention. 

The team used those reports from 2013 to 2022 to examine every IVF clinic in the country, which includes private practices and hospital-based clinics, and they used other databases and online searches to identify which clinics were affiliated with private equity firms. 

What they found was exponential, dramatic growth. To put it in context, in 2013, only 4% of fertility clinics in the United States were affiliated with private equity firms. But since then, the number has grown to be eight times as big.

“As of 2023, we estimate that 32% of IVF clinics were affiliated with private equity firms,” explains Dupree. He goes on, “And these clinics affiliated with these private equity firms are performing over half of the IVF cycles in the country.”

So what does that mean?

Dr. Dupree says, “There’s a lot we don’t know yet. It might be good for patients; it costs a lot of money to modernize IVF laboratory equipment and perform outreach to patients and private equity firms can provide capital to hopefully improve quality and patient care.”

He also explains that in other health care settings outside fertility care, there is data to suggest quality could decline while costs increase.

“We don’t know yet in the fertility world whether this is a net gain for patients or net loss,” he said. 

Dr. Dupree emphasizes how private equity-supported fertility care will be a crucial business model to continue examining, especially with the government’s recent interest in making IVF care more accessible to Americans with infertility.

He said, “Given how prevalent the business model is, we need to do more research and understand the benefits and risks — like the quality of care, cost of care, access to care — are they better or are they worse?”

As a top researcher in the area, Dr. Dupree and his team will continue his work looking into fertility care across the United States, including how IVF is covered by insurance companies, to help hopefully inform future health policies and help patients in the long run. 

A reminder that all Health Lab content including health news, best practices and research insights are for informational purposes only, and are not a substitute for professional medical guidance. Always seek the advice of a health care provider for questions about your health and treatment options.

For more on this story and for others like it, visit michiganmedicine.org/health-lab where you can also subscribe to our Health Lab newsletters to receive the latest in health, wellness and medical research information to your inbox each week. Health Lab is a part of the Michigan Medicine Podcast Network, and is produced by the Michigan Medicine Department of Communication. You can subscribe to Health Lab wherever you listen to podcasts.


More Articles About:

fertility Healthcare Medical School Michigan Medicine equity podcast
Health Lab Podcast in brackets with a background with a dark blue translucent layers over cells

Health Lab Podcast

Listen to more Health Lab podcasts - a part of the Michigan Medicine Podcast Network.

Featured News & Stories

UMich Med Mosaic on blue background with colorful geometric shapes
UMich Med Mosaic

Beyond the White Coat: Disability, Neurodiversity and Advocacy in Medical School

In this episode of UMich Med Mosaic, host Mackenzie Kay sits down with medical students Jill Maudlin, Sarah Renberg and Bella Johnson to discuss their experiences as disabled and neurodivergent trainees at the University of Michigan Medical School. They reflect on the personal journeys that led them to medicine, the challenges and strengths that accompany living with disabilities and chronic health conditions and the importance of representation within the medical profession. The conversation explores how disability shapes their approaches to patient care, advocacy and teamwork, as well as the role of the Medical Students for Disability Health Advocacy (MSDHA) organization in creating community and advancing accessibility initiatives. They also discuss Michigan’s accommodations in medical education, efforts to improve disability-related curriculum content and the importance of building a culture where disabled and neurodivergent students can thrive.
Minding Memory with a microphone and a shadow of a microphone on a blue background
Minding Memory

Antipsychotic Use in Nursing Homes: Balancing Medication Safety, Policy, and Dementia Care

In this episode, Lauren Gerlach and Matt Davis speak with Theresa Shireman, PhD, Director of the Center for Gerontology and Healthcare Research and a Professor of Health Services, Policy and Practice and Epidemiology at the Brown University School of Public Health. Dr. Shireman’s research focuses on pharmaceutical policy, pharmacoepidemiology, health services research, and medication use among vulnerable populations. Dr. Shireman discusses her recent study, "Impact of Federal Antipsychotic Use Policy in Nursing Homes on New Diagnoses for Approved Indications in Dementia Residents," published in the Journal of the American Geriatrics Society. The study examines whether federal policies designed to reduce antipsychotic use in nursing homes were associated with increases in new diagnoses of conditions, such as schizophrenia, that exclude residents from publicly report antipsychotic quality measures. Using an interrupted time-series design, the researchers examined changes following the 2012 National Partnership to Improve Dementia Care and the 2015 addition of antipsychotic use to the Nursing home Five-Star Quality Rating System. They found that neither policy was associated with an increase in new exclusionary diagnossees, challenging concerns that nursing homes were increasingly assigning these diagnoses to circumvent restrictions on antipsychotic use. The conversation also explores the benefits and risks of antipsychotic medications for people living with dementia, including the potential for serious adverse effects such as sedation, falls, stroke, and increased mortality. Dr. Shireman discusses how public reporting and financial incentives can influence prescribing practices,the limitations of using a single quality measure to evaluate nursing home care, and the importance of balancing medication safety and residents’ individual needs. The discussion highlights the need for shared decision-making among clinicians, nursing home staff, residents, and families, as well as greater investment in staffing, resources, and nonpharmacological approaches to improve quality of life for people living with dementia. The transcript for this episode can be found here.
Health Lab Podcast in brackets with a background with a dark blue translucent layers over cells
Health Lab Podcast

Human Rabies Exposures Growing Across the Country

Infectious disease experts weigh in on what to do if you think you’ve been exposed to rabies.
Well-Being at Michigan Medicine with Dr. Elizabeth Harry
Well-Being at Michigan Medicine

Learning Together: Making Space for Growth at Work

What if well-being starts with how we learn together? On this episode of Well-Being at Michigan Medicine, Elizabeth Harry, M.D., is joined by Rajesh Mangrulkar, M.D., FNAP, Executive Director of U-M’s Center for Interprofessional Practice and Education (IPE), Executive Director of Michigan Medicine RISE (Research. Innovation. Scholarship. Education), and primary care physician of internal medicine whose work focuses on organizational leadership and innovation, and Johnny McGraw, M.A., Marketing & Communications Specialist for both RISE and IPE, about building teams through human connection, psychological safety and learning. They discuss a meeting practice, why leaders shape culture and how investments in collaboration can help health care teams work without asking people to carry everything alone.
A hand holding a prescription bottle with a dollar bill in it
Health Lab

Top 7 tips for choosing Medicare prescription drug coverage for 2027

Prescription drug coverage through Medicare Advantage and Part D plans in traditional Medicare has changed for 2027, and older adults may not know about programs that could help with costs.
Minding memory above a microphone on a blue background
Minding Memory

Is the United States Lagging Behind Europe in Memory Improvement?

In this episode, Lauren & Matt speak with Neil Mehta, PhD who is the associate dean for research and a professor in the Department of Epidemiology at the University of Texas Medical Branch in Galveston. Dr. Mehta’s research focuses on US life expectancy trends, the effects of obesity on disability and mortality, the sources of socioeconomic status disparities in mortality, and patterns of health in the United States and Europe. Dr. Mehta talks about a recent manuscript from the NIA-funded TRENDS study called “Trends in Memory Function and Memory Impairment Among Older Adults in the United States and Europe, 1996 to 2018.”, which looks at data from several sources to compare trends in memory function across 13 different countries.